machineMD

machineMD 𝐬𝐞𝐥𝐞𝐜𝐭𝐞𝐝 𝐟𝐨𝐫 𝐀𝐝𝐯𝐚𝐧𝐜𝐢𝐧𝐠 𝐁𝐫𝐚𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞 MATTER, with support from the Lundbeck US Charitable Fund, has selected machineMD as one of the five most promising startups to participate in the Advancing Brain Health Innovation Challenge. "𝘖𝘤𝘶𝘭𝘰𝘮𝘦𝘵𝘳𝘪𝘤𝘴 𝘪𝘴 𝘰𝘯𝘦 𝘰𝘧 𝘵𝘩𝘦 𝘮𝘰𝘴𝘵 𝘱𝘳𝘰𝘮𝘪𝘴𝘪𝘯𝘨 𝘥𝘰𝘮𝘢𝘪𝘯𝘴 𝘧𝘰𝘳 𝘰𝘣𝘫𝘦𝘤𝘵𝘪𝘷𝘦𝘭𝘺 𝘮𝘦𝘢𝘴𝘶𝘳𝘪𝘯𝘨 𝘷𝘪𝘴𝘶𝘢𝘭 𝘴𝘪𝘨𝘯𝘴 𝘢𝘯𝘥 𝘴𝘺𝘮𝘱𝘵𝘰𝘮𝘴 𝘵𝘩𝘢𝘵 𝘱𝘦𝘰𝘱𝘭𝘦 𝘧𝘳𝘦𝘲𝘶𝘦𝘯𝘵𝘭𝘺 𝘦𝘯𝘤𝘰𝘶𝘯𝘵𝘦𝘳 𝘸𝘩𝘦𝘯 𝘭𝘪𝘷𝘪𝘯𝘨 𝘸𝘪𝘵𝘩 𝘳𝘢𝘳𝘦 𝘯𝘦𝘶𝘳𝘰𝘭𝘰𝘨𝘪𝘤𝘢𝘭 𝘥𝘪𝘴𝘦𝘢𝘴𝘦𝘴," said Avantika Naidu PT PhD, VP Business Development at machineMD. "𝘐'𝘮 𝘨𝘳𝘢𝘵𝘦𝘧𝘶𝘭 𝘵𝘰 𝘔𝘈𝘛𝘛𝘌𝘙 𝘢𝘯𝘥 𝘵𝘩𝘦 𝘓𝘶𝘯𝘥𝘣𝘦𝘤𝘬 𝘜𝘚 𝘊𝘩𝘢𝘳𝘪𝘵𝘢𝘣𝘭𝘦 𝘍𝘶𝘯𝘥 𝘧𝘰𝘳 𝘪𝘯𝘪𝘵𝘪𝘢𝘵𝘪𝘯𝘨 𝘵𝘩𝘪𝘴 𝘤𝘰𝘭𝘭𝘢𝘣𝘰𝘳𝘢𝘵𝘪𝘷𝘦 𝘢𝘱𝘱𝘳𝘰𝘢𝘤𝘩 𝘵𝘰 𝘪𝘮𝘱𝘳𝘰𝘷𝘦 𝘥𝘪𝘢𝘨𝘯𝘰𝘴𝘪𝘴 𝘢𝘯𝘥 𝘤𝘢𝘳𝘦." The goal of this Innovation Challenge is to discover solutions that transform care for individuals with rare neurological diseases by tackling barriers like specialist access, referral systems, patient literacy and the speed of accurate diagnosis. 🌐 Read More: https://lnkd.in/eiqNmFdp #Oculometrics #RareDiseases #BrainHealth #HealthcareInnovation

Meet Avantika Naidu PT PhD and PD Dr. Anke Salmen at #ACTRIMS 2025 this week to learn more about #oculometric findings for people living with #MS

New Study Highlights Reliable Gaze Measurements with neos® neos® provides reliable, consistent and robust measurements of eye movements, supporting its use in a vast array of clinical applications to objectively measure functional eye movements.     A recent study assessed the test-retest reliability of neos®, machineMD’s VR-based medical device, with promising results. Using a robotic eye system to simulate human eye movements, the study minimized biological variability and ensured precise measurement.    Key takeaways:  - High test-retest reliability of gaze precision  - Consistent performance across all gaze directions  - Robust results even under simulated noise    neos® has the potential to become an invaluable tool in routine eye examinations and more complex neuro-ophthalmic assessments of ocular motility in patients with neurological disorders.       #Neurodiagnostics #VRinHealthcare #EyeTracking #MedicalTechnology #Neuroscience #startupSwitzerland Avantika Naidu PT PhD, Ana Coito, PhD, Julian Lehmann, Dominik Brügger, Mathias Abegg Read the article: https://lnkd.in/ed4SeACR https://lnkd.in/e9dG4Cc3

𝐀𝐮𝐭𝐨𝐦𝐚𝐭𝐞𝐝 𝐌𝐞𝐚𝐬𝐮𝐫𝐞𝐦𝐞𝐧𝐭 𝐨𝐟 𝐒𝐭𝐫𝐚𝐛𝐢𝐬𝐦𝐮𝐬 𝐀𝐧𝐠𝐥𝐞 𝐔𝐬𝐢𝐧𝐠 𝐚 𝐂𝐨𝐦𝐦𝐞𝐫𝐜𝐢𝐚𝐥 𝐕𝐢𝐫𝐭𝐮𝐚𝐥 𝐑𝐞𝐚𝐥𝐢𝐭𝐲 𝐇𝐞𝐚𝐝𝐬𝐞𝐭 Objective, fast, accurate, space-saving ophthalmic assessments are crucial to drive clinical efficiency, especially given a shortage of skilled orthoptists. This paper #fromthearchives presents a good correlation between #strabismus angles measured using an automated alternate cover test in a #VR headset with gold standard measurements performed manually with the Harms tangent screen and clinical alternate cover test. Horizontal and vertical strabismus angles were measured in primary and peripheral gaze positions. 🌐 https://lnkd.in/dE6q6mxt Rino Vicini, Dominik Brügger, 𝐇𝐢𝐥𝐚𝐫𝐲 𝐆𝐫𝐚𝐛𝐞, Mathias Abegg Universitätsspital Zürich, Insel Gruppe, machineMD

January is National Glaucoma Awareness Month – Let’s spotlight innovative approaches in glaucoma diagnosis and management! 👁️  Glaucoma remains one of the leading causes of irreversible blindness, making it critical to explore new methods for early detection and better monitoring. A recently published pilot study offers promising insights in this direction.   The study by Karim Abi Said, René Höhn, Mariana Falcão, Ph.D. , Bruno Hauser, Avantika Naidu PT PhD and Mathias Abegg explores the use of virtual reality (VR) and pupillography to provide more objective measurements for glaucoma management and found that the pupillary light reflex (PLR) and relative afferent pupillary defect (RAPD) can be used to monitor glaucomatous optic nerve damage in a single eye over time, providing a more convenient and accurate approach to long-term glaucoma management. Learn more: Study in Thieme – Klinische Monatsblätter für Augenheilkunde  https://lnkd.in/e-fjE3Fj Let’s work together to raise awareness about glaucoma and support research that advances patient care! #GlaucomaAwareness #InnovativeDiagnostics #VirtualReality #EyeCare #GlaucomaResearch #GlaucomaAwarenessMonth  #Telemedicine #Opthalmology #Neurology #SitemMedTechHub #NeuroOphthalmology #startupswitzerland #swissmedtech #TranslationalMedicine #glaukoma #Optometry

🎉 We’re thrilled to announce that machineMD has been awarded the prestigious Innosuisse Certificate! This milestone signifies our readiness for sustainable growth and underscores the innovation driving our mission to revolutionize brain diagnostics. 🚀 A heartfelt thanks to Innosuisse and our coaches Armin W. Mäder and Dr. Heiko Visarius for guiding us through this transformative journey. The challenges were worth it, and the excitement has only just begun! Here’s to shaping the future of neuro-ophthalmology and making cutting-edge diagnostics accessible to all. 🌍💡 Let’s take the next bold steps together! 🧠👁️ #NeuroOphthalmology #Telemedicine #Ophthalmology #Neurology #StartupsSwitzerland #SwissMedTech #Innovation #DigitalHealth #HealthTech #Innosuisse #MedicalDevices #FutureOfHealthcare

Virtual Reality Pupillography swings the flashlight on Glaucoma Management     Relative Afferent Pupillary Defect (RAPD) measurements reliably detected asymmetries in optic nerve damage in glaucoma patients and, moreover, a combination of standard automated perimetry and RAPD led to improved prediction of the peripapillary retinal nerve fiber layer thickness, as measured by OCT. In the future, this may enable the use of pupillary light reflex over time to monitor glaucomatous optic nerve damage in a single eye.    A pilot study by Karim El-Koussy, René Höhn, Mariana Falcão, Ph.D., Bruno Hauser, Avantika Naidu PT PhD, and Mathias Abegg, combined neos™ pupillometry tests with standard automated perimetry and OCT to evaluate whether RAPD could sufficiently distinguish between the two eyes in asymmetric glaucoma and thus lay the foundation for using the pupillary light reflex (PLR) of a single eye to monitor progression longitudinally.     Read the Study in Thieme – klinische Monatsblätter für Augenheilkunde:     https://lnkd.in/e-fjE3Fj    #Telemedicine #Opthalmology #Neurology #SitemMedTechHub #NeuroOphthalmology #startupswitzerland #swissmedtech #TranslationalMedicine #glaucoma #Optometry

A new medical device changes the workflow of a practice - and opens up new possibilities. For the ebovis ophthalmology practice in Zurich, neos™ was the missing piece of the puzzle that made it possible to offer a complete, standardized, instrument-based eye examination. Today, neos™ is an integral part of this examination, which is carried out by an optician. The data is uploaded to a secure data cloud and analyzed remotely by two ophthalmologists. An example that could set a new standard - check out our movie. Many thanks to ebovis for the cooperation and valuable insights!    #startupswitzerland #Opththalmology #Neurology #NeuroOphthalmology #Optometry     https://lnkd.in/eD_ExfTZ 

Yesterday, we hosted Marie Reynders (MD, PhD candidate) at the IIT for a spontaneous talk co-hosted by our colleague Giovanni Bertolini (project lead) at the Institute of Optometry, in connection to an industry-academia collaboration project with machineMD as a partner. Marie shared with us how she discovered virtual reality as a diagnostics tool, specifically for persistent postural-perceptual dizziness. It was great to have you with us & learn from you Marie! cc Samuel Schenk, Luca Fluri, Oscar Alanso, Arzu Çöltekin

Zurich is home to ebovis, the world's first ophthalmology practice to offer a standardized, complete, apparative eye examination. The neos™ examination device developed by machineMD plays an important role in this. For the first time, it enables a comprehensive, automated neuro-ophthalmological examination.The people behind ebovis are neuro-ophthalmologist Dr. Mathias Abegg, ophthalmologist Dr. Sven Hirsch-Hoffmann and general practitioner Dr. Markus Abegg. With ebovis, they show that a efficient, high-quality, examination of eye structure and function can be performed by a medical assistant or optician alone - making eye care accessible for all. Read more about it in our article: https://lnkd.in/ePrYVwmy and watch our video: https://lnkd.in/eD_ExfTZ Many thanks to ebovis and Tanja Veljkovic, Markus Abegg, Sven Hirsch-Hoffmann, Mathias Abegg for these valuable insights into their clinical practice. #startupswitzerland #Opththalmology #Neurology #NeuroOphthalmology #Optometry